BOSTON SCIENTIFIC CORPORATION Cash and Restricted Cash
BOSTON SCIENTIFIC CORPORATION (BSX) had Cash and Restricted Cash of $753.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-03
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $753.00M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.64B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.15B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.48B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $753.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.64B 10-Q · filed 2026-05-01 |
| 2025-12-31 | $2.15B 10-Q · filed 2026-08-03 |
| 2025-09-30 | $1.48B 10-Q · filed 2025-11-03 |
| 2025-06-30 | $741.00M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $919.00M 10-Q · filed 2026-05-01 |
| 2024-12-31 | $606.00M 10-Q · filed 2026-08-03 |
| 2024-09-30 | $2.65B 10-Q · filed 2025-11-03 |
| 2024-06-30 | $3.06B 10-Q · filed 2025-08-01 |
| 2024-03-31 | $2.50B 10-Q · filed 2025-05-01 |
| 2023-12-31 | $1.05B 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.13B 10-Q · filed 2024-11-01 |
| 2023-06-30 | $620.00M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $763.00M 10-Q · filed 2024-05-01 |
| 2022-12-31 | $1.13B 10-K · filed 2026-02-17 |
| 2022-09-30 | $497.00M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $458.00M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $529.00M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $2.17B 10-K · filed 2025-02-18 |
| 2021-09-30 | $2.16B 10-Q · filed 2022-11-03 |
| 2021-06-30 | $2.90B 10-Q · filed 2022-08-04 |
| 2021-03-31 | $2.25B 10-Q · filed 2022-05-05 |
| 2020-12-31 | $2.00B 10-K · filed 2024-02-20 |
| 2020-09-30 | $2.28B 10-Q · filed 2021-11-04 |
| 2020-06-30 | $2.02B 10-Q · filed 2021-08-06 |
| 2020-03-31 | $700.00M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $607.00M 10-K · filed 2023-02-23 |
| 2019-09-30 | $676.00M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $2.82B 10-Q · filed 2020-08-05 |
| 2019-03-31 | $2.90B 10-Q · filed 2020-05-06 |
| 2018-12-31 | $829.00M 10-K · filed 2022-02-23 |
| 2018-09-30 | $980.00M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $994.00M 10-Q · filed 2019-07-30 |
| 2018-03-31 | $1.17B 10-Q · filed 2019-04-29 |
| 2017-12-31 | $1.02B 10-K · filed 2021-02-23 |
| 2017-09-30 | $690.00M 10-Q · filed 2018-10-29 |
| 2017-06-30 | $476.00M 10-Q · filed 2018-07-31 |
| 2016-12-31 | $487.00M 10-K · filed 2020-02-25 |
| 2015-12-31 | $400.00M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |